Tuesday, 12 February 2019
Department of Health
Cancer Services Provision
355. To ask the Minister for Health the steps being taken to ensure that cancer patients have access to innovative new cancer treatments at the same time as those in other European countries; and if he will make a statement on the matter. [6335/19]
A standard process is in place for the HSE reimbursement of new drugs, and new indications for existing drugs. This assessment process aims to ensure that decisions on the funding of drugs are clinically appropriate, fair, consistent and sustainable. The process is underpinned by the Health (Pricing and Supply of Medical Goods) Act 2013.
Many Irish cancer patients also access new cancer treatments through clinical trials. The National Cancer Strategy 2017-2026 envisages increased recruitment of patients to clinical trials over the period of the Strategy.